Synchronous presentation of renal cell carcinoma and cervical cancer: a rare oncological challenge
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20250894Keywords:
Synchronous malignancies, Renal cell carcinoma, Cervical cancer, Squamous cell carcinoma, Radical nephrectomy, ChemoradiationAbstract
Cervical cancer is the fourth most common cancer among women globally, with a high incidence and mortality, particularly in developing countries. Renal cell carcinoma (RCC), though less common, comprises 2% of global cancer diagnoses. The synchronous occurrence of RCC and cervical cancer is extremely rare, with less than 5% of cervical cancer cases presenting with another primary malignancy. We report a case of a 47-year-old multiparous woman diagnosed with FIGO stage IIIB cervical cancer, who, during staging and evaluation, was incidentally found to have a synchronous renal cell carcinoma. During the course, imaging revealed a mass in the right kidney, confirmed to be RCC via biopsy. A multidisciplinary tumor board recommended surgical management for the RCC, and the patient underwent a right radical nephrectomy, which confirmed clear cell RCC. Postoperatively, the patient resumed treatment for cervical cancer with concurrent chemoradiation. This case highlights the importance of comprehensive diagnostic imaging in patients with pelvic malignancies to detect any coexisting primary tumors. Early identification and treatment of synchronous malignancies are critical for optimizing patient outcomes, and this case contributes valuable insight into the rare co-occurrence of RCC and cervical cancer.
Metrics
References
Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Can J Clin. 2024;74(3):229-63. DOI: https://doi.org/10.3322/caac.21834
Sathishkumar K, Chaturvedi M, Das P, Stephen S, Mathur P. Cancer incidence estimates for 2022 & projection for 2025: result from National Cancer Registry Programme, India. Indian J of Medical Res. 2022;156(4):598-607. DOI: https://doi.org/10.4103/ijmr.ijmr_1821_22
Padala SA, Barsouk A, Thandra KC, Saginala K, Mohammed A, Vakiti A, Rawla P, Barsouk A. Epidemiology of renal cell carcinoma. World J Oncol. 2020;11(3):79 DOI: https://doi.org/10.14740/wjon1279
Takeda T, Sagae S, Koizumi M, Terasawa K, Ishioka S, Takashima S, Kudo R. Multiple primary malignancies in patients with gynecologic cancer. Int J of Gynecol Cancer. 1995;5(1):34-9. DOI: https://doi.org/10.1046/j.1525-1438.1995.05010034.x
Soni M, Bhatia S, Gupta D. Synchronous carcinoma cervix with renal cell carcinoma: an incidental finding. IJISR. 2024;536:178-80. DOI: https://doi.org/10.38124/ijisrt/IJISRT24JUN536
Shaukat F, Mansha MA, Ali N, Khan AM, Abbasi AN. Incidental renal cell carcinoma in pelvic malignancies. Cureus. 2019;11(1):67-9. DOI: https://doi.org/10.7759/cureus.3829
Sharma M, Hussain A, Sharma M. Synchronous Renal Cell Carcinoma with Carcinoma Cervix: An Unusual Clinical Presentation. J South Asian Feder Menopause Soc. 2020;8(1):52–3. DOI: https://doi.org/10.5005/jp-journals-10032-1197